MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Inducing motor cortical plasticity in Parkinson’s Disease patients using subthalamic deep brain stimulation and repetitive transcranial magnetic stimulation

    C. Rinchon, C. Gunraj, N. Drummond, T. Hoque, KHS. Chen, R. Chen (Toronto, Canada)

    Objective: To investigate whether motor cortical plasticity can be induced in Parkinson’s disease (PD) patients by pairing subthalamic deep brain stimulation (STN-DBS) and repetitive transcranial…
  • 2022 International Congress

    Clinical phenotype of non-manifesting carriers of mutations in the GBA and LRRK2 genes

    N. Omer, N. Giladi, A. Bar-Shira, M. Gana-Weisz, O. Goldstein, O. Asias, J. Shirvan, J. Cedarbaum, M. Kestenbaum, A. Orr-Urtreger, R. Alcalay, A. Mirelman, A. Thaler (Tel-Aviv, Israel)

    Objective: To explore the influence of carrying mutations in both the GBA and LRRK2 genes (dual mutation carriers) on risk for future development of Parkinson's…
  • 2022 International Congress

    Outcomes after Deep Brain Stimulation (DBS) surgery in patients with young-onset Parkinson’s disease

    L. Jackson, B. Klassen, K. Lee, K. Miller, A. Hassan, R. Savica (Rochester, USA)

    Objective: To assess outcomes after deep brain stimulation (DBS) in patient with young-onset Parkinson’s disease (PD). Background: DBS is a surgical procedure which effectively treats…
  • 2022 International Congress

    Blood biomarkers and their association with non-motor symptoms in early Parkinson’s Disease

    J. Kaur, S. Ng, N. Chia, X. Deng, J. Tan, X. Choi, D. Heng, Z. Xu, K. Tay, W. Au, A. Ng, E. Tan, L. Tan (central, Singapore)

    Objective: To identify if baseline blood biomarkers are associated with non-motor symptoms in early PD. Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder with…
  • 2022 International Congress

    Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study

    S. Isaacson, N. Giladi, F. Stocchi, L. Salin, N. Vostokova, W. Poewe (Boca Raton, USA)

    Objective: To report long-term safety and tolerability data from the ongoing BeyoND study (NCT02726386) for patients who continued treatment past the one-year primary endpoint. Background:…
  • 2022 International Congress

    Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease

    DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim (Seoul, Republic of Korea)

    Objective: This study aimed to compare the clinical progression between brain-first and body-first PD groups using cardiac sympathetic denervation (CSD). Background: Brain-first and body-first Parkinson’s…
  • 2022 International Congress

    Preferences for discussing sexual health concerns

    G. Bronner, S. Peleg Nesher, Y. Manor, A. Rosenberg, S. Naor, A. Ezra, R. Mallin, R. Hurvitz Alon, T. Gurevich (Tel Aviv, Israel)

    Objective: To investigate the sexual needs of PwP, and understand their preferences for discussing sexual health concerns.To propose an intervention framework tailored for PwP in…
  • 2022 International Congress

    LRRK2 and GBA major variants in the New York Mount Sinai BioMe Biobank

    A. Yoo, R. Ortega, V. Katsnelson, A. Debebe, A. Rendon, M. Picker, D. Raymond, S. Bressman, L. Ozelius, I. Peter, R. Saunders-Pullman (New York, USA)

    Objective: To characterize the frequency of major LRRK2 and GBA variants in a multi-ethnic New York cohort with and without Parkinson disease (PD). Background: There…
  • 2022 International Congress

    Quality of Life and Motor Outcomes for Parkinson’s Disease Patients 12 Months After Deep Brain Stimulation in China

    Y. Zhang, L. Chen, B. Sun, X. Wang, J. Wang, J. Wang, J. Woods, K. Stromberg, H. Shang (Chengdu, China)

    Objective: Demonstrate improvement in Parkinson’s disease (PD)-related quality of life (QoL) for Deep Brain Stimulation (DBS) patients in a prospective, multicenter study conducted in China.…
  • 2022 International Congress

    History of Comorbidities and their Association with Developing Cognitive Dysfunction in PD

    C. Venuto, K. Kieburtz, K. Herbst, G. Smith (Rochester, USA)

    Objective: To examine comorbidities associated with incident cognitive dysfunction in PD. Background: The risk of dementia is up to six-times higher in PD compared to…
  • « Previous Page
  • 1
  • …
  • 335
  • 336
  • 337
  • 338
  • 339
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley